Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trialMehreen S. Datoo, Nsajigwa Misidai, Alassane Dicko et al.|The Lancet|2024Cited by 345
Detection of malaria parasites in dried human blood spots using mid-infrared spectroscopy and logistic regression analysisEmmanuel P. Mwanga, Fredros O. Okumu, Marta F. Maia et al.|Malaria Journal|2019Cited by 68
The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling studyNora Schmit, Peter Winskill, Hillary M. Topazian et al.|The Lancet Infectious Diseases|2024Cited by 48
Sporozoite immunization: innovative translational science to support the fight against malariaThomas L. Richie, Stephen L. Hoffman, L. W. Preston Church et al.|Expert Review of Vaccines|2023Cited by 46
A Phase III Randomised Controlled Trial Evaluating the Malaria Vaccine Candidate R21/Matrix-M™ in African ChildrenMehreen Datoo, Adrian V. S. Hill, Alassane Dicko et al.|SSRN Electronic Journal|2023Cited by 29